Canis ISSN: 2398-2942

Clemastine

Contributor(s): Rosanna Marsella

Introduction

Class of drug

  • Antihistamine, H1 blocker.

Description

Storage requirements

  • Tight, light-resistant containers.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Management of allergic disease.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmocokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Hansson H, Bergvall K, Bondesson U, Hedeland M & Törneke K (2004)Clinical pharmacology of clemastine in healthy dogs.Vet Derm15 (3), 152-158PubMed.
  • Garcia G, DeMora F, Ferrer L & Puigdemont A (1997)Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.Am J Vet Res58(3), 293-297.
  • Paterson S (1995)Additive benefits of EFA's in dogs with atopic dermatitis after partial response to antihistamine therapy.JSAP36(9), 389-394.

Other sources of information

  • PlumbVeterinary Drug handbook3 edn. pp 167-168.

ADDED